4//SEC Filing
Crowe Suzanne 4
Accession 0000950170-25-082422
CIK 0001762303other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:41 PM ET
Size
8.0 KB
Accession
0000950170-25-082422
Insider Transaction Report
Form 4
Crowe Suzanne
Director
Transactions
- Award
Common Stock
2025-01-21+10,022→ 46,934 total - Award
Stock Options (Right to Buy)
2025-01-21+4,295→ 4,295 totalExercise: $8.73From: 2026-01-21Exp: 2035-01-21→ Common Stock (4,295 underlying)
Footnotes (4)
- [F1]Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025.
- [F2]Includes unvested RSUs.
- [F3]Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above.
- [F4]On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025.
Documents
Issuer
AVITA Medical, Inc.
CIK 0001762303
Entity typeother
Related Parties
1- filerCIK 0001816242
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:41 PM ET
- Size
- 8.0 KB